WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02269 WUXI BIO

Closed 12-23 16:08:09

32.820

-0.320

-0.97%

High33.560	Low32.620	Vol14.54M
Open33.160	D1 Closing33.140	Amplitude2.84%
Mkt Cap135.48B	Tradable Cap135.48B	Total Shares4.13B
T/O479.48M	T/O Rate0.35%	Tradable Shares4.13B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"WUXI BIO","latestPrice":32.82,"timestamp":1766477289006,"preClose":33.14,"halted":0,"volume":14543700,"delay":0,"floatShares":4128000000,"shares":4128000000,"eps":0.9113489880835706,"marketStatus":"Closed","change":-0.32,"latestTime":"12-23 16:08:09","open":33.16,"high":33.56,"low":32.62,"amount":479477814,"amplitude":0.028365,"askPrice":32.84,"askSize":104000,"bidPrice":32.82,"bidSize":195500,"shortable":3,"etf":0,"ttmEps":1.095701435836406,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":33.14,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0.462023,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.4699,"impliedVolPercentile":0.1138},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2593418477","title":"WuXi XDC Selected to Manufacture Akari Therapeutics' AKTX-101 for Phase 1 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418477","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418477?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:30","pubTimestamp":1766496647,"startTime":"0","endTime":"0","summary":"Akari Therapeutics, Plc has selected WuXi XDC Cayman Inc. as its contract development and manufacturing organization  partner for the GMP manufacturing of AKTX-101, Akari's lead antibody drug conjugate  program. The collaboration aims to support IND-enabling activities and the production of GMP-grade material for a planned Phase 1 first-in-human clinical trial. WuXi XDC will provide end-to-end ADC development and manufacturing services, supporting Akari's clinical development timeline for AKTX-101, which is expected to begin clinical trials in late 2026 or early 2027, pending regulatory clearance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via Glob","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL4LCcxw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","LU0823426308.USD","AKTX","BK1589","IE00B3QW5Z07.USD","LU0979878070.USD","SG9999002562.SGD","LU0181495838.USD","02269","BK4007","LU0516422366.SGD","LU0856984785.SGD","IE00BGHQF748.EUR","LU0516422440.USD","BK4588","LU2095319765.USD","SG9999014039.USD","LU0140636845.USD","LU0320764599.SGD","LU0456846285.SGD","LU0516423174.USD","LU0572944931.SGD","LU3063872942.SGD","SG9999014005.SGD","LU0326950275.SGD","LU0417516902.SGD","SG9999014021.USD","SG9999014013.SGD","BK4112","LU2039709279.SGD","LU1688375341.USD","LU0348825331.USD","LU0052750758.USD","LU1242518931.SGD","LU0819121731.USD","NDAQ","SG9999014674.SGD","LU0516423091.SGD","02268","LU1794554557.SGD","LU1242518857.USD","LU0823426480.USD","LU0348735423.USD","LU0588546209.SGD","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0359202008.SGD","LU0314104364.USD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2593510015","title":"Wuxi Biologics (Cayman) Stock Sheds 3.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2593510015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593510015?lang=en_us&edition=fundamental","pubTime":"2025-12-22 16:31","pubTimestamp":1766392260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 3.0% to 33.14 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 25801.77.The stock's fall snapped a three-day winning streak.Wuxi Biologics  Inc. closed 22% short of its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 46.9 million shares, compared to the 50-day average of 33.3 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","BK1576","02269","LU1720050803.USD","SG9999002463.SGD","LU0572944931.SGD","SG9999002562.SGD","LU0819121731.USD","BK1610","LU0417516902.SGD","LU0516422952.EUR","LU0307460666.USD","LU1794554557.SGD","LU0823426308.USD","LU0327786744.USD","BK1589","LU0516422366.SGD","LU0456827905.SGD","LU0516423174.USD","LU0140636845.USD","LU0516423091.SGD","LU0456846285.SGD","LU1242518857.USD","LU0823426480.USD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0052750758.USD","LU0039217434.USD","LU0516422440.USD","LU1880383366.USD","LU0051755006.USD","LU1242518931.SGD","LU0181495838.USD","BK1141","BK1521","LU0326950275.SGD","LU0417516738.SGD","LU0043850808.USD","LU1688375341.USD","LU0588546209.SGD","LU0348825331.USD","LU0359202008.SGD","LU0856984785.SGD","LU0359201612.USD","LU0979878070.USD","LU2039709279.SGD","LU0348735423.USD"],"gpt_icon":0},{"id":"2593144580","title":"How Investors Are Reacting To WuXi Biologics (Cayman) (SEHK:2269) CDP Dual “A” ESG Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2593144580","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593144580?lang=en_us&edition=fundamental","pubTime":"2025-12-21 02:13","pubTimestamp":1766254401,"startTime":"0","endTime":"0","summary":"Earlier in 2025, WuXi Biologics was named to CDP’s “A” lists for both Climate Change and Water Security, reflecting its progress on environmental stewardship and its 2050 net‑zero value-chain target.\nThis dual “A” recognition, supported by initiatives in energy efficiency, renewable power and Water Excellence Stewardship, can broaden WuXi Biologics’ appeal to ESG-focused biopharma clients and investors.\nWe’ll now assess how WuXi Biologics’ CDP dual “A” recognition for climate and water...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/how-investors-are-reacting-to-wuxi-biologics-cayman-sehk2269","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/how-investors-are-reacting-to-wuxi-biologics-cayman-sehk2269","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0417516902.SGD","LU0181495838.USD","LU0140636845.USD","LU0516422440.USD","LU0516422952.EUR","SG9999002562.SGD","LU0043850808.USD","LU1688375341.USD","BK1589","LU0588546209.SGD","CDP","LU0456846285.SGD","ESG","LU0348825331.USD","LU1794554557.SGD","ISBC","LU0359201612.USD","BK1521","LU0516423174.USD","LU2039709279.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0307460666.USD","BK4223","BK1576","BK1610","LU0348735423.USD","LU1242518931.SGD","LU0417516738.SGD","LU0823426480.USD","LU0326950275.SGD","LU0856984785.SGD","BK4211","LU1880383366.USD","LU0327786744.USD","BK1141","LU1242518857.USD","LU0039217434.USD","LU0979878070.USD","LU1720050803.USD","02269","LU3063872942.SGD","LU0819121731.USD","LU0320764599.SGD","LU0516423091.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0708995583.HKD","LU0516422366.SGD","LU0456827905.SGD"],"gpt_icon":0},{"id":"1122364808","title":"Hong Kong Market Insights: Hainan Free Trade Port Closure Holds Major Significance; Autonomous Driving Sector Sees Intensive Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1122364808","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122364808?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:21","pubTimestamp":1766150506,"startTime":"0","endTime":"0","summary":"【Market Overview】   The market showed signs of vitality today, unlike the sluggish performance in recent days, with both mainland and Hong Kong markets advancing steadily. The Hang Seng Index closed...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"85e8aafb51ba0ad706197d405ff70b96","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","BK1115","LU0456827905.SGD","BK1521","09880","BK1575","LU0572944931.SGD","BK1564","LU2097828805.USD","LU0359201612.USD","LU0320764599.SGD","LU0039217434.USD","01316","LU2242644610.SGD","LU0052750758.USD","LU0516422440.USD","01880","LU0326950275.SGD","LU0516422952.EUR","LU2039709279.SGD","BK1179","09868","02498","601995","LU2097828631.EUR","BK1147","BK1588","IE00B0JY6N72.USD","LU0348766576.USD","BK1161","LU1969619763.USD","LU1242518931.SGD","09660","LU0348735423.USD","SG9999002828.SGD","BK1141","LU0516423174.USD","BK1589","LU0307460666.USD","BK1509","LU2097828557.USD","LU1303224171.USD","LU0327786744.USD","BK1183","LU0516423091.SGD","LU0359201885.HKD","LU0051755006.USD","BK1191","LU0417516738.SGD","LU2488822045.USD","BK1207","06160","BK1144","LU0455707207.USD","LU0516422366.SGD","LU2328871848.SGD","BK1613","BK1516","LU0502904849.HKD","LU0819121731.USD","BK1224","LU0856984785.SGD","01318","LU0593848301.USD","BK1501","LU1023057109.AUD","LU0979878070.USD","BK1500","03759","LU1688375341.USD","01999","09863","BK1610","LU1794554557.SGD","BK0276","SG9999002463.SGD","BK1539","LU1719994722.HKD","BK1587","LU1781817850.SGD","LU0359202008.SGD","LU0456846285.SGD","BK1583","01057","02431","LU0043850808.USD","BK1109","BK1119","00699","LU1720050803.USD","LU1880383366.USD","02269","LU2097828714.EUR","02050","BK1507","HK0000165453.HKD","LU0823426308.USD","LU1242518857.USD","LU1251922891.USD","LU1580142542.USD","LU2097828474.EUR","LU0140636845.USD","LU1508157978.USD","LU1770034418.SGD","LU0348767384.USD","LU0348825331.USD","LU0181495838.USD","02039","LU0417516902.SGD","02533","01801","LU3063872942.SGD","LU2663582299.SGD","LU0823426480.USD","LU0708995583.HKD","03908","LU0227179875.USD","BK1576","SG9999002562.SGD","06821","BK1163"],"gpt_icon":1},{"id":"2592151154","title":"Wuxi Biologics (Cayman) Stock Advances 4.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2592151154","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592151154?lang=en_us&edition=fundamental","pubTime":"2025-12-19 16:30","pubTimestamp":1766133000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 4.4% to 34.16 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25690.53.This was the stock's third consecutive day of gains.Wuxi Biologics  Inc. closed 20% short of its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 43.8 million shares, compared to the 50-day average of 33.1 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","BK1141","LU1242518857.USD","LU0051755006.USD","LU0516423091.SGD","LU1720050803.USD","BK1589","LU0140636845.USD","LU0456827905.SGD","LU0516422366.SGD","BK1576","LU0181495838.USD","LU0823426480.USD","LU0348735423.USD","LU0819121731.USD","SG9999002463.SGD","LU0326950275.SGD","LU0856984785.SGD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0823426308.USD","LU0979878070.USD","LU0043850808.USD","LU0516422440.USD","LU0456846285.SGD","LU0516423174.USD","LU0307460666.USD","LU1688375341.USD","02269","LU0572944931.SGD","LU0417516738.SGD","BK1521","LU0320764599.SGD","LU0359201612.USD","LU3063872942.SGD","LU0417516902.SGD","LU0039217434.USD","LU0052750758.USD","LU0348825331.USD","LU1880383366.USD","LU0359202008.SGD","LU0516422952.EUR","LU1242518931.SGD","LU1794554557.SGD","SG9999002562.SGD","LU0327786744.USD","BK1610","LU0708995583.HKD"],"gpt_icon":0},{"id":"2592213718","title":"WuXi Biologics Receives CDP “A” Ratings for Climate Change and Water Security","url":"https://stock-news.laohu8.com/highlight/detail?id=2592213718","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592213718?lang=en_us&edition=fundamental","pubTime":"2025-12-19 12:26","pubTimestamp":1766118399,"startTime":"0","endTime":"0","summary":"WuXi Biologics  Inc. has been awarded the highest “A” ratings by CDP for both Climate Change and Water Security for 2025. The company’s greenhouse gas emissions reduction targets, including both near-term and net-zero goals, have been approved by the Science Based Targets initiative . WuXi Biologics has implemented measures such as energy efficiency programs, process optimization, and the use of renewable energy, with its facility in Ireland now operating on 100% renewable electricity. The company also received an “A” rating in CDP’s Supplier Engagement assessment, recognizing its efforts to promote climate action and sustainable practices across its supply chain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics  Inc. publ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL4wPhfc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0588546209.SGD","02269","BK1589","LU0456827905.SGD","LU0307460666.USD","BK1521","LU0856984785.SGD","LU1880383366.USD","LU0327786744.USD","LU0572944931.SGD","LU0823426308.USD","LU1242518857.USD","LU0140636845.USD","LU0359201612.USD","LU0320764599.SGD","LU0979878070.USD","LU0516423091.SGD","LU1688375341.USD","LU0039217434.USD","LU0051755006.USD","LU0348825331.USD","LU0181495838.USD","LU0417516902.SGD","LU0052750758.USD","BK1610","LU0417516738.SGD","LU0516422440.USD","LU0326950275.SGD","LU0516422952.EUR","LU3063872942.SGD","LU2039709279.SGD","LU1794554557.SGD","LU0823426480.USD","SG9999002463.SGD","LU0708995583.HKD","LU0516422366.SGD","BK1576","LU0359202008.SGD","LU0456846285.SGD","IE00B0JY6N72.USD","SG9999002562.SGD","LU0819121731.USD","LU1242518931.SGD","LU0348735423.USD","LU1720050803.USD","LU0043850808.USD","BK1141"],"gpt_icon":0},{"id":"1116587365","title":"Pharmaceutical Stocks Rebound Sharply This Morning with Asymchem and Wuxi Biologics Both Rising Over 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116587365","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116587365?lang=en_us&edition=fundamental","pubTime":"2025-12-19 11:13","pubTimestamp":1766113983,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks showed a notable rebound this morning, led by the CRO and innovative drug sectors. At the time of writing, Asymchem Laboratories (06821) rose 6.07% to HK$76.85, while Wuxi...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","06821","LU0516423091.SGD","LU0516422952.EUR","LU0039217434.USD","LU0417516738.SGD","BK1576","LU0051755006.USD","LU0856984785.SGD","SG9999002562.SGD","LU0327786744.USD","LU0588546209.SGD","LU0823426308.USD","LU0320764599.SGD","002821","LU0516423174.USD","LU0456846285.SGD","IE00B0JY6N72.USD","LU0456827905.SGD","BK1574","LU0307460666.USD","LU0819121731.USD","LU1328615791.USD","LU1880383366.USD","LU2039709279.SGD","LU0417516902.SGD","LU0359202008.SGD","LU3063872942.SGD","BK1141","LU0572944931.SGD","09939","LU0181495838.USD","LU1242518857.USD","LU1242518931.SGD","LU0348825331.USD","LU0348735423.USD","LU0516422440.USD","BK1610","02269","LU0043850808.USD","BK1515","LU0979878070.USD","LU1794554557.SGD","LU0052750758.USD","BK1589","LU0359201612.USD","BK0132","BK1161","LU0823426480.USD","SG9999002463.SGD","BK1191","LU0708995583.HKD","159938","BK0239","BK1521","LU0140636845.USD","LU0516422366.SGD","LU0326950275.SGD","LU1688375341.USD"],"gpt_icon":0},{"id":"2592196014","title":"Wuxi Biologics (Cayman) Stock Rallies 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196014","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592196014?lang=en_us&edition=fundamental","pubTime":"2025-12-17 16:32","pubTimestamp":1765960320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 1.5% to 32.54 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.9% to 25468.78.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 24% short of its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 18.3 million shares, compared to the 50-day average of 32.6 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","LU0516422952.EUR","LU0326950275.SGD","LU0456827905.SGD","BK1589","LU0856984785.SGD","LU0516422440.USD","LU0979878070.USD","LU1720050803.USD","LU3063872942.SGD","LU1688375341.USD","02269","LU1242518857.USD","SG9999002562.SGD","LU0181495838.USD","LU0320764599.SGD","LU0043850808.USD","SG9999002463.SGD","LU1880383366.USD","BK1141","LU0708995583.HKD","BK1610","LU0823426480.USD","LU0307460666.USD","LU0516423091.SGD","LU0359202008.SGD","LU0051755006.USD","LU0348735423.USD","LU0359201612.USD","LU0456846285.SGD","BK1576","LU0039217434.USD","LU0052750758.USD","LU0516422366.SGD","LU2039709279.SGD","BK1521","LU0417516738.SGD","LU0588546209.SGD","LU0823426308.USD","LU0417516902.SGD","IE00B0JY6N72.USD","LU0140636845.USD","LU0516423174.USD","LU0348825331.USD","LU0327786744.USD","LU1794554557.SGD","LU0819121731.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2591619992","title":"Wuxi Biologics (Cayman) Stock Slides 3.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2591619992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591619992?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:30","pubTimestamp":1765787400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 3.1% to 32.44 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25628.88.Wuxi Biologics  Inc. closed 24% below its 52-week high of HK$42.60, which the company reached Oct. 3.Trading volume totaled 27.6 million shares, compared to the 50-day average of 32.2 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B0JY6N72.USD","LU1794554557.SGD","LU0359201612.USD","LU0320764599.SGD","LU0043850808.USD","LU0823426480.USD","BK1610","LU0348825331.USD","LU0051755006.USD","LU0348735423.USD","LU0359202008.SGD","LU0708995583.HKD","LU0823426308.USD","LU0856984785.SGD","LU0572944931.SGD","LU0516422952.EUR","SG9999002562.SGD","02269","LU1242518931.SGD","LU0588546209.SGD","LU0052750758.USD","LU0516423174.USD","LU1242518857.USD","LU1688375341.USD","LU2039709279.SGD","LU0417516738.SGD","LU3063872942.SGD","LU0327786744.USD","LU0140636845.USD","LU0516423091.SGD","LU0417516902.SGD","LU0979878070.USD","LU0516422366.SGD","LU0456846285.SGD","LU0456827905.SGD","LU1880383366.USD","LU0181495838.USD","BK1521","BK1141","BK1589","LU0039217434.USD","SG9999002463.SGD","LU0326950275.SGD","BK1576","LU0307460666.USD","LU0819121731.USD","LU1720050803.USD","LU0516422440.USD"],"gpt_icon":0},{"id":"2590169623","title":"Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2590169623","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590169623?lang=en_us&edition=fundamental","pubTime":"2025-12-09 16:32","pubTimestamp":1765269120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.9% to 33.56 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25434.23.This was the stock's second consecutive day of gains.Wuxi Biologics  Inc. closed 21% short of its 52-week high of HK$42.60, which the company reached Oct. 3.Trading volume totaled 42.5 million shares, compared to the 50-day average of 32.9 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0588546209.SGD","LU0140636845.USD","BK1610","LU0823426480.USD","LU0516422366.SGD","02269","LU0359201612.USD","LU3063872942.SGD","SG9999002463.SGD","LU0417516902.SGD","LU0051755006.USD","LU0819121731.USD","LU0516423091.SGD","LU0516422952.EUR","LU1688375341.USD","LU0348825331.USD","LU1720050803.USD","BK1141","LU0043850808.USD","LU0516423174.USD","LU1242518931.SGD","LU1242518857.USD","LU0039217434.USD","BK1589","LU2039709279.SGD","LU0417516738.SGD","LU0052750758.USD","BK1521","LU0979878070.USD","LU0327786744.USD","LU0359202008.SGD","LU0516422440.USD","LU0856984785.SGD","LU0456827905.SGD","LU0456846285.SGD","LU0348735423.USD","LU1794554557.SGD","SG9999002562.SGD","LU1880383366.USD","LU0572944931.SGD","LU0320764599.SGD","LU0307460666.USD","LU0708995583.HKD","LU0181495838.USD","LU0326950275.SGD","LU0823426308.USD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"1189609357","title":"HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 21%, Sirnaomics up 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189609357","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189609357?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:07","pubTimestamp":1765246076,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. Ascletis Pharma rose 21%; Sirnaomics rose 11%; Joinn Laboratories rose 10%; WuXi XDC rose 5%; Pharmaron and WuXi Biologics rose 4%; WuXi AppTec rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"eb673bcce88aebafcbc37fb491eb2df2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","02268","03759","02269","06127","02257","02359"],"gpt_icon":0},{"id":"2589867451","title":"Wuxi Biologics (Cayman) Stock Falls 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2589867451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589867451?lang=en_us&edition=fundamental","pubTime":"2025-12-05 16:32","pubTimestamp":1764923520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slid 1.0% to 32.62 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 26085.08.Wuxi Biologics  Inc. closed 23% below its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 35.8 million shares, compared to the 50-day average of 32.9 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","LU0516422952.EUR","LU0326950275.SGD","LU0456827905.SGD","BK1589","LU0856984785.SGD","LU0516422440.USD","LU0979878070.USD","LU1720050803.USD","LU3063872942.SGD","LU1688375341.USD","02269","LU1242518857.USD","SG9999002562.SGD","LU0181495838.USD","LU0320764599.SGD","LU0043850808.USD","SG9999002463.SGD","LU1880383366.USD","BK1141","LU0708995583.HKD","BK1610","LU0823426480.USD","LU0307460666.USD","LU0516423091.SGD","LU0359202008.SGD","LU0051755006.USD","LU0348735423.USD","LU0359201612.USD","LU0456846285.SGD","BK1576","LU0039217434.USD","LU0052750758.USD","LU0516422366.SGD","LU2039709279.SGD","BK1521","LU0417516738.SGD","LU0588546209.SGD","LU0823426308.USD","LU0417516902.SGD","IE00B0JY6N72.USD","LU0140636845.USD","LU0516423174.USD","LU0348825331.USD","LU0327786744.USD","LU1794554557.SGD","LU0819121731.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2589895193","title":"WuXi Biologics (SEHK:2269) Deepens Middle East Ties With Qatar CRDMO Hub Plan – What Really Changes?","url":"https://stock-news.laohu8.com/highlight/detail?id=2589895193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589895193?lang=en_us&edition=fundamental","pubTime":"2025-12-05 14:12","pubTimestamp":1764915123,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) recently announced a Memorandum of Understanding with the Qatar Free Zones Authority to establish its first integrated CRDMO center in the Middle East, extending its global biologics development and manufacturing network into the region.\nBy pairing its one-stop CRDMO capabilities in complex biologics with Qatar’s push to build a regional biotech hub, WuXi Biologics is positioning itself as an early infrastructure partner in shaping the Middle East’s biopharmaceutical...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-sehk2269-deepens-middle-east-ties-with-qatar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-sehk2269-deepens-middle-east-ties-with-qatar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B66KJ199.SGD","LU0708995583.HKD","BK1576","02269","LU1720050803.USD","SG9999002463.SGD","LU0572944931.SGD","SG9999002562.SGD","LU0819121731.USD","BK1610","LU0417516902.SGD","LU0516422952.EUR","LU0307460666.USD","LU1794554557.SGD","LU0823426308.USD","LU0327786744.USD","BK1589","IE00B19Z4B17.USD","LU0456827905.SGD","LU0516423174.USD","HUBG","LU0140636845.USD","LU0516423091.SGD","LU0456846285.SGD","LU1242518857.USD","LU0823426480.USD","LU3063872942.SGD","LU0320764599.SGD","LU0052750758.USD","LU0039217434.USD","LU1880383366.USD","IE0031619046.USD","LU0051755006.USD","LU0181495838.USD","BK1141","LU1242518931.SGD","BK1521","LU0326950275.SGD","LU0417516738.SGD","LU0043850808.USD","LU1688375341.USD","BK4131","IE00B7SZL793.SGD","LU0348825331.USD","LU0588546209.SGD","LU0359202008.SGD","LU0359201612.USD","LU0979878070.USD","LU2039709279.SGD","LU0348735423.USD"],"gpt_icon":0},{"id":"1192142821","title":"WUXI BIO: Breaking News","url":"https://stock-news.laohu8.com/highlight/detail?id=1192142821","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192142821?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:25","pubTimestamp":1764858339,"startTime":"0","endTime":"0","summary":"WUXI BIO: Breaking News","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU0516422440.USD","LU0516422952.EUR","LU0140636845.USD","LU0327786744.USD","LU0572944931.SGD","LU0819121731.USD","BK1610","LU1720050803.USD","LU0456827905.SGD","LU1794554557.SGD","LU0051755006.USD","LU0359201612.USD","LU0456846285.SGD","LU0516423091.SGD","LU0181495838.USD","LU0039217434.USD","LU0823426308.USD","LU1688375341.USD","LU3063872942.SGD","LU0856984785.SGD","LU2039709279.SGD","LU0348825331.USD","LU0348735423.USD","LU0417516738.SGD","BK1589","02269","LU0043850808.USD","LU0516422366.SGD","LU0052750758.USD","LU0516423174.USD","BK1141","SG9999002463.SGD","LU0359202008.SGD","LU0979878070.USD","LU0708995583.HKD","LU1242518857.USD","LU1242518931.SGD","LU1880383366.USD","SG9999002562.SGD","BK1521","LU0326950275.SGD","LU0417516902.SGD","LU0823426480.USD","BK1576","LU0307460666.USD","LU0320764599.SGD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"1158710973","title":"Biotech Stocks Surge: Wuxi Bio and Wuxi Apptec Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1158710973","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158710973?lang=en_us&edition=fundamental","pubTime":"2025-12-04 18:50","pubTimestamp":1764845445,"startTime":"0","endTime":"0","summary":"On December 4, Hong Kong stocks rose steadily, with the Hang Seng Index closing up 0.68% at 25,935.9 points. The Hang Seng Tech Index gained 1.45%, while the Hang Seng China Enterprises Index...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","SG9999002463.SGD","SG9999002562.SGD","LU0572944931.SGD","LU1794554557.SGD","LU0181495838.USD","BK1610","LU0039217434.USD","LU0823426308.USD","LU0516423174.USD","LU0327786744.USD","02269","LU0140636845.USD","BK1574","LU0819121731.USD","BK0216","06978","LU0359202008.SGD","LU1979443071.USD","LU2328871848.SGD","LU0348735423.USD","LU0823426480.USD","BK1576","BK1583","LU2045819591.USD","LU1808992512.USD","LU0043850808.USD","LU0359201612.USD","159992","LU2495084118.USD","LU1969619763.USD","LU0456827905.SGD","LU0856984785.SGD","LU0516422366.SGD","BK1521","LU1242518857.USD","LU0052750758.USD","BK1161","LU2242644610.SGD","603259","BK1589","LU3063872942.SGD","LU0516422440.USD","LU0417516902.SGD","LU0348825331.USD","LU0417516738.SGD","LU1997244956.HKD","LU1997245177.USD","02359","LU1046422090.SGD","LU1242518931.SGD","LU1997245094.SGD","IE00B0JY6N72.USD","LU0456842615.SGD","LU1934453819.USD","LU1688375341.USD","LU0456846285.SGD","LU0051755006.USD","LU0979878070.USD","LU0320764599.SGD","LU0516422952.EUR","LU2039709279.SGD","LU0307460666.USD","LU2488822045.USD","LU0588546209.SGD","LU0516423091.SGD","LU2125910500.SGD","BK1141","LU0708995583.HKD","LU1720050803.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2588046470","title":"Wuxi Biologics (Cayman) Stock Rises 7.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588046470?lang=en_us&edition=fundamental","pubTime":"2025-12-04 16:30","pubTimestamp":1764837000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 7.1% to 32.94 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.7% to 25935.90.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 23% short of its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 61.3 million shares, compared to the 50-day average of 32.9 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU0708995583.HKD","LU0039217434.USD","BK1576","LU0051755006.USD","LU0327786744.USD","LU0819121731.USD","LU0856984785.SGD","IE00B0JY6N72.USD","LU2039709279.SGD","LU1880383366.USD","LU0516422366.SGD","LU1242518857.USD","BK1589","LU0320764599.SGD","LU0572944931.SGD","LU0140636845.USD","LU1242518931.SGD","LU0359201612.USD","LU3063872942.SGD","BK1610","LU0348735423.USD","LU0823426308.USD","SG9999002463.SGD","LU0456827905.SGD","LU0417516902.SGD","LU0823426480.USD","LU0588546209.SGD","LU0979878070.USD","LU1720050803.USD","LU0516422440.USD","LU1688375341.USD","LU1794554557.SGD","LU0181495838.USD","LU0516422952.EUR","LU0326950275.SGD","LU0516423091.SGD","BK1521","02269","LU0516423174.USD","LU0348825331.USD","LU0417516738.SGD","LU0307460666.USD","BK1141","SG9999002562.SGD","LU0456846285.SGD","LU0043850808.USD","LU0359202008.SGD"],"gpt_icon":0},{"id":"1133471563","title":"Hong Kong Stocks Surge: CRO Concept Stocks Rally in Afternoon Session with WUXI BIO (02269) Up Over 7%; Analysts Highlight Industry Consolidation Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1133471563","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133471563?lang=en_us&edition=fundamental","pubTime":"2025-12-04 14:40","pubTimestamp":1764830440,"startTime":"0","endTime":"0","summary":"CRO concept stocks experienced a rapid surge in the afternoon session. As of press time, WUXI BIO (02269) rose 4.94% to HK$32.28, GENSCRIPT BIO (01548) gained 3.8% to HK$15.01, WUXI APPTEC (02359)...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","LU3063872942.SGD","HK0000306685.HKD","LU0348825331.USD","LU0327786744.USD","HK0000306701.USD","LU0856984785.SGD","LU1720050803.USD","LU0456846285.SGD","LU0588546209.SGD","01548","LU0819121731.USD","BK1583","LU2242644610.SGD","BK1576","LU0979878070.USD","LU0572944931.SGD","LU0823426308.USD","LU0140636845.USD","LU0516422440.USD","LU0307460666.USD","LU0708995583.HKD","LU0320764599.SGD","LU0417516738.SGD","SG9999002463.SGD","LU2045819591.USD","BK1589","LU1880383366.USD","LU1688375341.USD","BK1521","02269","02359","LU0516423091.SGD","LU0359202008.SGD","LU0039217434.USD","LU2039709279.SGD","LU0043850808.USD","LU1242518931.SGD","LU0326950275.SGD","LU0348735423.USD","LU0417516902.SGD","LU0516422366.SGD","LU0359201612.USD","LU0456827905.SGD","LU0516422952.EUR","LU0052750758.USD","LU0516423174.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU0181495838.USD","BK1610","LU1046422090.SGD","LU2125910500.SGD","SG9999002562.SGD","LU1794554557.SGD","HK0000320223.HKD","BK1141","LU1242518857.USD","LU0823426480.USD","03347"],"gpt_icon":0},{"id":"1127489049","title":"HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127489049","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127489049?lang=en_us&edition=fundamental","pubTime":"2025-12-04 10:26","pubTimestamp":1764815206,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up about 4%; Zai Lab up over 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2c8d9a47d2e27ece6292940208c30d20","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","09995","09606","06606","06978","02269","02137","01672","02359","02268","03759","09966","03347"],"gpt_icon":0},{"id":"1109808809","title":"HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1109808809","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109808809?lang=en_us&edition=fundamental","pubTime":"2025-12-03 13:18","pubTimestamp":1764739138,"startTime":"0","endTime":"0","summary":"Bitech stocks fell in Hong Kong. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2c8d9a47d2e27ece6292940208c30d20","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","02137","02268","02359","03759","09995","02269","01672","06978","09966","06606","03347","09606"],"gpt_icon":0},{"id":"2588359035","title":"WuXi Biologics Extends Global Crdmo Network to Qatar Through Strategic Mou Signed With Qatar Free Zones Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=2588359035","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588359035?lang=en_us&edition=fundamental","pubTime":"2025-12-02 16:46","pubTimestamp":1764665193,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA49GTK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","LU0140636845.USD","BK1589","LU0572944931.SGD","LU0359202008.SGD","LU1242518857.USD","LU0456827905.SGD","LU1688375341.USD","LU0516423091.SGD","LU0823426308.USD","LU3063872942.SGD","LU0456846285.SGD","LU0417516738.SGD","SG9999002562.SGD","LU0417516902.SGD","LU1242518931.SGD","LU0348735423.USD","LU0516422366.SGD","LU1720050803.USD","SG9999002463.SGD","LU0979878070.USD","LU0307460666.USD","IE00B0JY6N72.USD","LU0348825331.USD","LU1880383366.USD","LU0359201612.USD","LU0516423174.USD","LU0327786744.USD","LU0326950275.SGD","LU1794554557.SGD","LU0516422952.EUR","LU0708995583.HKD","BK1610","LU2039709279.SGD","02269","LU0052750758.USD","LU0819121731.USD","LU0856984785.SGD","LU0823426480.USD","LU0320764599.SGD","LU0051755006.USD","LU0039217434.USD","LU0181495838.USD","LU0516422440.USD","BK1576","BK1521","LU0588546209.SGD","LU0043850808.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0216},{"period":"1month","weight":0.0844},{"period":"3month","weight":-0.161},{"period":"6month","weight":0.2895},{"period":"1year","weight":0.9471},{"period":"ytd","weight":0.8872}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.037371},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003108},{"month":3,"riseRate":0.625,"avgChangeRate":0.020153},{"month":4,"riseRate":0.375,"avgChangeRate":-0.000625},{"month":5,"riseRate":0.5,"avgChangeRate":0.00166},{"month":6,"riseRate":0.625,"avgChangeRate":0.064583},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081469},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.015223}],"exchange":"SEHK","name":"WUXI BIO","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI BIO,02269,WUXI BIO股票,WUXI BIO股票老虎,WUXI BIO股票老虎国际,WUXI BIO行情,WUXI BIO股票行情,WUXI BIO股价,WUXI BIO股市,WUXI BIO股票价格,WUXI BIO股票交易,WUXI BIO股票购买,WUXI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}